Track topics on Twitter Track topics that are important to you
RedHill Biopharma has obtained positive Phase III results for its Crohn’s disease treatment, which targets a certain type of gut bacteria. Crohn’s disease is a type of inflammatory bowel disease, characterized by acute flare-ups and periods of symptom-free remission, that ...
The post Israeli Crohn’s Disease Drug Rakes in Positive Phase III Results appeared first on Labiotech.eu.
Original Article: Israeli Crohn’s Disease Drug Rakes in Positive Phase III ResultsNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...